Manulife Financial Corporation one of the dominant life insurers. Manulife reports earnings through six divisions and has five major operating divisions - Asia, Canada, U.S. Insurance and U.S. Wealth Management and Corporate. The Global Wealth and Asset Management offers a broad range of personal and family-oriented wealth management products and services focused on individuals and business markets. The segment has three core business lines - John Hancock Wealth Asset Management, John Hancock Variable Annuities and John Hancock Fixed Products. Corporate and Other is comprised of the earnings on assets backing capital. The Canadian division offers a diverse portfolio of products, services and distribution channels. The segment also markets life, health and specialty products, such as travel insurance, to consumers through a number of alternative distribution channels. Through Manulife Bank, the segment offers a variety of lending products including fixed and variable rate mortgages....
+See More2017-12-15 07:42:00 Friday ET

Disney acquires 21st Century Fox in a $52 billion landmark deal. This deal has a total value of about $66 billion while Disney assumes $14 billion of Fox
2027-07-31 13:25:00 Saturday ET

In the broader context of stablecoins for asset tokenization worldwide, many governments now seek to enter the global markets for stablecoins and other U.S.
2019-03-31 11:40:00 Sunday ET

AYA Analytica free finbuzz podcast channel on YouTube March 2019 In this podcast, we discuss several topical issues as of March 2019: (1) Sargent-Wallac
2019-06-13 10:26:00 Thursday ET

The Chinese Xi administration may choose to leverage its state dominance of rare-earth elements to better balance the current Sino-U.S. trade war. In recent
2019-01-05 11:39:00 Saturday ET

Reuters polls show that most Americans blame President Trump for the recent U.S. government shutdown. President Trump remains adamant about having to shut d
2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its